Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Statistics

Total Valuation

VRDN has a market cap or net worth of $1.10 billion. The enterprise value is $415.36 million.

Market Cap	1.10B
Enterprise Value	415.36M

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025, before market open.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

VRDN has 81.48 million shares outstanding. The number of shares has increased by 51.68% in one year.

Current Share Class	81.48M
Shares Outstanding	81.48M
Shares Change (YoY)	+51.68%
Shares Change (QoQ)	+20.52%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	106.93%
Float	76.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3,674.92
Forward PS	3,860.98
PB Ratio	2.42
P/TBV Ratio	2.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1,375.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.43, with a Debt / Equity ratio of 0.03.

Current Ratio	15.43
Quick Ratio	14.99
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-98.17

Financial Efficiency

Return on equity (ROE) is -48.48% and return on invested capital (ROIC) is -32.26%.

Return on Equity (ROE)	-48.48%
Return on Assets (ROA)	-30.32%
Return on Invested Capital (ROIC)	-32.26%
Return on Capital Employed (ROCE)	-43.06%
Revenue Per Employee	$2,112
Profits Per Employee	-$1.46M
Employee Count	143
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.76% in the last 52 weeks. The beta is 1.09, so VRDN's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-22.76%
50-Day Moving Average	16.69
200-Day Moving Average	18.06
Relative Strength Index (RSI)	32.74
Average Volume (20 Days)	766,310

Short Selling Information

The latest short interest is 10.00 million, so 12.27% of the outstanding shares have been sold short.

Short Interest	10.00M
Short Previous Month	9.57M
Short % of Shares Out	12.27%
Short % of Float	13.00%
Short Ratio (days to cover)	11.40

Income Statement

In the last 12 months, VRDN had revenue of $302,000 and -$208.56 million in losses. Loss per share was -$3.07.

Revenue	302,000
Gross Profit	-237.95M
Operating Income	-299.04M
Pretax Income	-228.06M
Net Income	-208.56M
EBITDA	-298.50M
EBIT	-299.04M
Loss Per Share	-$3.07

Balance Sheet

The company has $717.58 million in cash and $23.12 million in debt, giving a net cash position of $694.47 million or $8.52 per share.

Cash & Cash Equivalents	717.58M
Total Debt	23.12M
Net Cash	694.47M
Net Cash Per Share	$8.52
Equity (Book Value)	671.64M
Book Value Per Share	5.96
Working Capital	690.59M

Cash Flow

In the last 12 months, operating cash flow was -$232.32 million and capital expenditures -$511,000, giving a free cash flow of -$232.83 million.

Operating Cash Flow	-232.32M
Capital Expenditures	-511,000
Free Cash Flow	-232.83M
FCF Per Share	-$2.86

Margins

Gross Margin	n/a
Operating Margin	-99,018.21%
Pretax Margin	-89,387.09%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VRDN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-51.68%
Shareholder Yield	-51.68%
Earnings Yield	-18.79%
FCF Yield	-20.98%

Analyst Forecast

The average price target for VRDN is $36.44, which is 170.03% higher than the current price. The consensus rating is "Buy".

Price Target	$36.44
Price Target Difference	170.03%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	409.61%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 13, 2020. It was a reverse split with a ratio of 0.0666666:1.

Last Split Date	Nov 13, 2020
Split Type	Reverse
Split Ratio	0.0666666:1

Scores

VRDN has an Altman Z-Score of 8.14.

Altman Z-Score	8.14
Piotroski F-Score	n/a